IDENTIFICATION OF BIOMARKERS FOR DETECTING PROSTATE CANCER

摘要

The present invention relates to a method of qualifying prostate cancer status in a subject comprising: (a) measuring at least one of the disclosed biomarkers in a sample from the subject and (b) correlating the measurement with prostate cancer status. The invention further relates to kits for qualifying prostate cancer status in a subject.

主权项

1. A method of qualifying prostate cancer status in a subject comprising:
(a) measuring at least one biomarker in a sample from the subject, wherein the biomarker is selected from the group consisting of Marker I: having a molecular weight of about 7.808 kD Marker II: having a molecular weight of about 14.576 kD Marker III: having a molecular weight of about 2.062 kD Marker IV: having a molecular weight of about 7.974 kD Marker V: having a molecular weight of about 6.677 kD Marker VI: having a molecular weight of about 3.936 kD Marker VII: having a molecular weight of about 60.958 kD Marker VIII: having a molecular weight of about 5.149 kD Marker IX: having a molecular weight of about 5.861 kD Marker X: having a molecular weight of about 28.098 kD Marker XI: having a molecular weight of about 2.996 kD Marker XII: having a molecular weight of about 24.346 kD Marker XIII: having a molecular weight of about 6.722 kD Marker XIV: having a molecular weight of about 5.999 kD Marker XV: having a molecular weight of about 6.158 kD Marker XVI: having a molecular weight of about 55.785 kD Marker XVII: having a molecular weight of about 2.540 kD Marker XVIII: having a molecular weight of about 8.019 kD Marker XIX: having a molecular weight of about 4.658 kD Marker XX: having a molecular weight of about 14.703 kD Marker XXI: having a molecular weight of about 2.68 kD Marker XXII: having a molecular weight of about 3.16 kD Marker XXIII: having a molecular weight of about 10.3 kD Marker XXIV: having a molecular weight of about 10.8 kD Marker XXV: having a molecular weight of about 12.7 kD Marker XXVI: having a molecular weight of about 17.9 kD Marker XXVII: having a molecular weight of about 2.79 kD Marker XXVIII: having a molecular weight of about 3.32 kD Marker XXIX: having a molecular weight of about 4.29 kD Marker XXX: having a molecular weight of about 15.9 kD Marker XXXI: having a molecular weight of about 16.1 kD Marker XXXII: having a molecular weight of about 16.3 kD, and combinations thereof, and (b) correlating the measurement with prostate cancer status.